Seagen (SGEN) News Today → Americans Now Need $1.46M to Retire… (From Crypto 101 Media) (Ad) Free SGEN Stock Alerts Notice: This company has been marked as potentially delisted and may not be actively trading. Add Compare Share Share HeadlinesStock AnalysisAnalyst ForecastsEarningsHeadlinesInsider TradesOwnershipShort InterestSocial MediaSustainabilityStock AnalysisAnalyst ForecastsEarningsHeadlinesInsider TradesOwnershipShort InterestSocial MediaSustainability All Sources Trusted Sources MarketBeat.com Benzinga Bloomberg MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha The Street The Wall Street Journal Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative April 13, 2024 | wsj.comTwo Brothers, a Big Biotech Bet and an $8 Billion PayoutMarch 20, 2024 | msn.comRon Baron Portfolio Magic: Building Your Financial FutureMarch 13, 2024 | msn.comBailouts are back, Fed outlook reassessed, Pfizer M&A - what's moving marketsMarch 1, 2024 | bizjournals.comPfizer shutting down Seagen's $350M construction project in EverettFebruary 24, 2024 | finance.yahoo.comNeuralink’s First Brain Implant Patient Can Control Mouse with Thoughts, Musk SaysFebruary 23, 2024 | finance.yahoo.comMRNA Feb 2024 64.000 putFebruary 23, 2024 | finance.yahoo.comMRNA Feb 2024 77.000 callFebruary 23, 2024 | msn.comPfizer adds bull at Guggenheim on ex-COVID prospectsFebruary 22, 2024 | finance.yahoo.comMRNA Feb 2024 67.000 putFebruary 12, 2024 | msn.comPfizer touts cancer efforts in first Super Bowl commercialFebruary 10, 2024 | finance.yahoo.comPRIMECAP Management's Strategic Exits and New Positions Highlight Q4 MovesJanuary 29, 2024 | msn.comPfizer Q4 results on deck amid gloomy earnings outlookJanuary 28, 2024 | za.investing.comPro Research: Wall Street eyes Seagen's growth trajectoryJanuary 16, 2024 | marketbeat.comAllspring Global Investments Holdings LLC Lowers Stake in Seagen Inc. (NASDAQ:SGEN)Allspring Global Investments Holdings LLC lowered its stake in shares of Seagen Inc. (NASDAQ:SGEN - Free Report) by 19.2% in the third quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 103,341 shares of the biotechnoloJanuary 13, 2024 | marketbeat.comYelin Lapidot Holdings Management Ltd. Makes New $5.22 Million Investment in Seagen Inc. (NASDAQ:SGEN)Yelin Lapidot Holdings Management Ltd. acquired a new position in Seagen Inc. (NASDAQ:SGEN - Free Report) during the third quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The fund acquired 24,600 shares of the biotechnology company's stocJanuary 12, 2024 | marketbeat.comOregon Public Employees Retirement Fund Has $3.41 Million Position in Seagen Inc. (NASDAQ:SGEN)Oregon Public Employees Retirement Fund cut its position in Seagen Inc. (NASDAQ:SGEN - Free Report) by 30.3% in the 3rd quarter, according to its most recent filing with the Securities and Exchange Commission. The institutional investor owned 16,068 shares of the biotechnology company's stock afteJanuary 11, 2024 | marketbeat.comING Groep NV Lowers Stock Holdings in Seagen Inc. (NASDAQ:SGEN)ING Groep NV decreased its position in shares of Seagen Inc. (NASDAQ:SGEN - Free Report) by 15.3% during the third quarter, according to its most recent disclosure with the Securities & Exchange Commission. The institutional investor owned 67,298 shares of the biotechnology company's stock aftDecember 30, 2023 | ca.finance.yahoo.comSGEN Jan 2024 210.000 putDecember 30, 2023 | ca.finance.yahoo.comSGEN Jan 2024 235.000 put(CONTRDecember 30, 2023 | uk.finance.yahoo.comSGEN Dec 2023 195.000 put(CONTRDecember 27, 2023 | za.investing.comPro Research: Wall Street dives into Seagen's oncology advancesDecember 22, 2023 | seekingalpha.comHBM Gets Health Boost From Drug Licensing DealsDecember 14, 2023 | msn.comPfizer Shares Slump After Waning Covid Sales Hurt 2024 OutlookDecember 14, 2023 | marketbeat.comPfizer: From pandemic hero to investor jitters (SGEN)Pfizer's transitions from pandemic success to market concerns: analyzing revenue stagnation, investor reactions, and the company's strategic roadmap for growth.December 14, 2023 | marketbeat.comTrading was temporarily halted for "SGEN" at 07:12 PM with a stated reason of "News pending."December 13, 2023 | seekingalpha.comTake-Two Interactive Software to replace Seagen on Nasdaq-100 IndexDecember 13, 2023 | msn.comPfizer to Establish New Oncology Division Following Completion of Seagen DealDecember 13, 2023 | msn.comPfizer slips as 2024 guidance with Seagen buyout disappointsDecember 13, 2023 | marketbeat.comGTS Securities LLC Makes New $14.89 Million Investment in Seagen Inc. (NASDAQ:SGEN)GTS Securities LLC bought a new position in shares of Seagen Inc. (NASDAQ:SGEN - Free Report) during the second quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor bought 77,342 shares of the biotechnology company's stDecember 12, 2023 | marketbeat.comPolar Asset Management Partners Inc. Makes New $12.92 Million Investment in Seagen Inc. (NASDAQ:SGEN)Polar Asset Management Partners Inc. purchased a new position in Seagen Inc. (NASDAQ:SGEN - Free Report) during the 2nd quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The fund purchased 67,135 shares of the biotechnology company's stock, valDecember 12, 2023 | nasdaq.comPfizer gets OK for $43-bln Seagen deal after donating cancer drug rightsDecember 11, 2023 | benzinga.comWhat the Options Market Tells Us About SeagenDecember 11, 2023 | marketbeat.comSeagen Inc. (NASDAQ:SGEN) Shares Acquired by Hudson Bay Capital Management LPHudson Bay Capital Management LP lifted its position in shares of Seagen Inc. (NASDAQ:SGEN - Free Report) by 251.0% during the 2nd quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The institutional investor owned 303,291 shares of the biotechDecember 11, 2023 | businesswire.com88% of patients with advanced stage classical Hodgkin Lymphoma in trial remained progression free at 24 months –December 10, 2023 | finance.yahoo.comADCETRIS® (brentuximab vedotin) Plus Novel Immunotherapy Combination Delivers 100% Progression Free Survival at 12 months in Phase 2 Trial of Patients with Early Stage Classical Hodgkin LymphomaDecember 10, 2023 | marketbeat.comCanyon Capital Advisors LLC Makes New $20.47 Million Investment in Seagen Inc. (NASDAQ:SGEN)Canyon Capital Advisors LLC bought a new position in shares of Seagen Inc. (NASDAQ:SGEN - Free Report) in the 2nd quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The fund bought 106,363 shares of the biotechnology company's stock,December 8, 2023 | benzinga.comA Closer Look at Seagen's Options Market DynamicsDecember 8, 2023 | marketbeat.comMarshall Wace LLP Grows Stock Holdings in Seagen Inc. (NASDAQ:SGEN)Marshall Wace LLP boosted its stake in shares of Seagen Inc. (NASDAQ:SGEN - Free Report) by 45.6% during the 2nd quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The firm owned 340,407 shares of the biotechnology company's stock after buying an addiDecember 7, 2023 | benzinga.com$100 Invested In Seagen 20 Years Ago Would Be Worth This Much TodayDecember 6, 2023 | msn.comSeagen's breast cancer drug shows positive results in combination therapy trialDecember 6, 2023 | markets.businessinsider.comSeagen: HER2CLIMB-02 Study Results Reinforce Clinical Activity Of TUKYSADecember 6, 2023 | finance.yahoo.comTUKYSA® (tucatinib) in Combination with Antibody-Drug Conjugate ado-Trastuzumab Emtansine Improves Progression-Free Survival in Patients with Previously Treated HER2-Positive Metastatic Breast CancerDecember 5, 2023 | msn.comSeagen gains amid options trades, optimism for FTC approval for Pfizer dealDecember 3, 2023 | marketbeat.comPolar Capital Holdings Plc Reduces Stock Holdings in Seagen Inc. (NASDAQ:SGEN)Polar Capital Holdings Plc reduced its stake in Seagen Inc. (NASDAQ:SGEN - Free Report) by 11.0% during the 2nd quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The fund owned 489,000 shares of the biotechnology company's stock after selling 60,39December 3, 2023 | benzinga.comSeagen Stock (NASDAQ:SGEN), Guidance and ForecastDecember 1, 2023 | finance.yahoo.comWhy Is Seattle Genetics (SGEN) Down 0.7% Since Last Earnings Report?December 1, 2023 | finance.yahoo.comSeagen's (SGEN) Combo Drug Expanded-Use sBLA Gets Priority TagDecember 1, 2023 | marketbeat.comBlackRock Inc. Has $2.32 Billion Position in Seagen Inc. (NASDAQ:SGEN)BlackRock Inc. boosted its position in Seagen Inc. (NASDAQ:SGEN - Free Report) by 7.6% during the second quarter, according to the company in its most recent 13F filing with the SEC. The fund owned 12,041,819 shares of the biotechnology company's stock after buying an additional 850,697 shares duriNovember 30, 2023 | businesswire.comFDA Grants Priority Review for Supplemental Biologics License Application (sBLA) of PADCEV ® (enfortumab vedotin-ejfv) with KEYTRUDA ® (pembrolizumab) for First-Line ...November 30, 2023 | msn.comFDA to decide on approving Keytruda/Padcev combo therapy by May 9 Get Seagen News Delivered to You Automatically Sign up to receive the latest news and ratings for SGEN and its competitors with MarketBeat's FREE daily newsletter. Email Address A ‘DeFi Summer’ Projected! (Ad)Top analysts are predicting DeFi coins to see massive gains in the coming months… During this dubbed ‘DeFi Summer…’ A coin that has been called the “DeFi pioneer” is poised to shoot up 3-7x! Just click here to learn how you can access this coin right now. SGEN Media Mentions By Week SGEN Media SentimentLearn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. SGEN News Sentiment▼0.000.54▲Average Medical News Sentiment SGEN News CoverageLearn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. SGEN Articles This Week▼04▲SGEN Articles Average Week Get Seagen News Delivered to You Automatically Sign up to receive the latest news and ratings for SGEN and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies: Takeda Pharmaceutical News IQVIA News Cencora News Centene News IDEXX Laboratories News Alcon News Moderna News Humana News Haleon News GE HealthCare Technologies News Headlines Tools: Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:SGEN) was last updated on 5/17/2024 by MarketBeat.com Staff From Our PartnersGold Set to EXPLODE!Gold Safe ExchangeHow Biden has already won 2024Porter & CompanyBiden Nomination CANCELED?The Freeport SocietyThe Overlooked Retirement Asset You Probably Don’t OwnCrypto 101 Media348 million Americans lives to END as we know it?The Oxford ClubA once-in-a-century investment opportunityStansberry ResearchCharles Payne Demystifies OptionsUnstoppable ProsperityBiden FINISHED On June 13th?Paradigm Press Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Seagen Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
